Table 3.
Clinical characteristics of endometrial hyperemia and nonendometrial hyperemia cohorts.
| Hyperemia cohort (n = 354) | Nonhyperemia cohort (n = 2982) | P value | 95% CI | |
|---|---|---|---|---|
| Age, years | 31.19 ± 3.52 | 31.89 ± 3.52 | 0.101 | 0.925–1.007 |
| Infertility duration, years | 3.80 ± 2.37 | 3.75 ± 2.52 | 0.792 | 0.950–1.070 |
| BMI (kg/m2) | 24.77 ± 3.39 | 23.64 ± 3.46 | <0.001 | 1.064–1.164 |
| Infertility | ||||
| Primary infertility % | 192 (54.24%) | 1498 (50.23%) | 0.855 | 0.775–1.235 |
| Secondary infertility % | 162 (45.76%) | 1484 (49.77%) | ||
| bFSH (UI/L) | 6.53 ± 1.77 | 6.71 ± 1.87 | 0.975 | 0.914–1.097 |
| bLH (UI/L) | 6.91 ± 4.10 | 5.57 ± 3.01 | <0.001 | 1.058–1.149 |
| bE2 (pg/ml) | 34.33 ± 13.78 | 34.77 ± 13.94 | 0.774 | 0.998–1.009 |
| bP (ng/ml) | 0.50 ± 0.29 | 0.52 ± 0.26 | 0.144 | 0.380–1.152 |
| bT(ng/ml) | 0.32 ± 0.16 | 0.26 ± 0.14 | <0.001 | 4.917–19.946 |
| PRL (ng/ml) | 16.74 ± 6.59 | 17.30 ± 6.25 | 0.823 | 0.976–1.019 |
| AMH (ng/ml) | 7.21 ± 4.83 | 4.92 ± 2.78 | <0.001 | 1.028–1.095 |
| CA125 (U/ml) | 20.89 ± 8.85 | 22.99 ± 7.17 | 0.470 | 0.997–1.007 |
| CHOL(mmol/L) | 4.83 ± 0.87 | 4.78 ± 0.86 | 0.880 | 0.559–1.647 |
| LDL-C (mmol/L) | 2.84 ± 0.78 | 2.85 ± 0.95 | 0.946 | 0.558–1.724 |
| TG (mmol/L) | 1.22 ± 0.92 | 1.08 ± 0.86 | 0.675 | 0.731–1.225 |